Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rivaroxaban for Suspension

Approval Number

国药准字HJ20220044

CompanyBAYER AG

Registration Date

April 29, 2022

Drug Information

Generic Name

利伐沙班干混悬剂

Dosage Form

干混悬剂

Strength

103.4mg

Drug Type

化学药品

Registration Date

April 29, 2022

Expiry Date

April 28, 2027

Company Information

Applicant Company

Company NameBAYER AG

Company Address

51368 Leverkusen, Germany

Manufacturing Company

Company NameBAYER AG

Company Address

Kaiser-Wilhelm-Allee, 51368 Leverkusen, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy